Cargando…
Thrombotic thrombocytopenic purpura - analysis of clinical features, laboratory characteristics and therapeutic outcome of 24 patients treated at a Tertiary Care Center in Saudi Arabia
OBJECTIVE: Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease. The primary aim was overall response rate (ORR) assessment in the treated patients METHODS: This retrospective study included 24 patients treated during 2006-2015. TTP patients with microangiopathic hemolysis (MAHA)...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Professional Medical Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216308/ https://www.ncbi.nlm.nih.gov/pubmed/28083052 http://dx.doi.org/10.12669/pjms.326.11274 |
_version_ | 1782491900095234048 |
---|---|
author | Iqbal, Shahid Zaidi, Syed Z. A. Motabi, Ibraheem H Alshehry, Nawal Faiez AlGhamdi, Mubarak S. Tailor, Imran Khan |
author_facet | Iqbal, Shahid Zaidi, Syed Z. A. Motabi, Ibraheem H Alshehry, Nawal Faiez AlGhamdi, Mubarak S. Tailor, Imran Khan |
author_sort | Iqbal, Shahid |
collection | PubMed |
description | OBJECTIVE: Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease. The primary aim was overall response rate (ORR) assessment in the treated patients METHODS: This retrospective study included 24 patients treated during 2006-2015. TTP patients with microangiopathic hemolysis (MAHA) and thrombocytopenia were included. We analyzed clinical features, laboratory characteristics and treatment outcomes of 24 TTP patients treated at our tertiary care center (KFMC). RESULTS: Twenty-four TTP patients (18 females; 6 males) had a mean age of 33.5±13.9 years; 22(91%) had neurologic features, 7(29%) fever, 10(42%) renal impairment; 4(20.83%) cardiac manifestations; 22(91.7%) had triad with additional neurologic abnormalities; only 2(8.2%) had pentad of TTP. Majority (54.16%) had idiopathic TTP. All patients received therapeutic plasma exchange (TPE); 23(95.8%) received adjunctive corticosteroids and 13(54.2%) received rituximab either due to refractoriness to TPE on ~day7, or earlier. Twenty-one out of 24 (87.5%) achieved complete remission (CR) without any subsequent relapse. At 22 months (median, range 1-113), 20 patients (83.3%) are alive at the time of report. Three patients died during acute episode because of sever disease or delayed treatment and one died in CR. CONCLUSION: TPE, steroids and or rituximab was very effective in preventing high risk of mortality and achieving durable CR in 87.5% of patients. More awareness is needed for early diagnosis and early referral to centers with appropriate tertiary care facilities.. |
format | Online Article Text |
id | pubmed-5216308 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Professional Medical Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-52163082017-01-12 Thrombotic thrombocytopenic purpura - analysis of clinical features, laboratory characteristics and therapeutic outcome of 24 patients treated at a Tertiary Care Center in Saudi Arabia Iqbal, Shahid Zaidi, Syed Z. A. Motabi, Ibraheem H Alshehry, Nawal Faiez AlGhamdi, Mubarak S. Tailor, Imran Khan Pak J Med Sci Original Article OBJECTIVE: Thrombotic thrombocytopenic purpura (TTP) is a life-threatening disease. The primary aim was overall response rate (ORR) assessment in the treated patients METHODS: This retrospective study included 24 patients treated during 2006-2015. TTP patients with microangiopathic hemolysis (MAHA) and thrombocytopenia were included. We analyzed clinical features, laboratory characteristics and treatment outcomes of 24 TTP patients treated at our tertiary care center (KFMC). RESULTS: Twenty-four TTP patients (18 females; 6 males) had a mean age of 33.5±13.9 years; 22(91%) had neurologic features, 7(29%) fever, 10(42%) renal impairment; 4(20.83%) cardiac manifestations; 22(91.7%) had triad with additional neurologic abnormalities; only 2(8.2%) had pentad of TTP. Majority (54.16%) had idiopathic TTP. All patients received therapeutic plasma exchange (TPE); 23(95.8%) received adjunctive corticosteroids and 13(54.2%) received rituximab either due to refractoriness to TPE on ~day7, or earlier. Twenty-one out of 24 (87.5%) achieved complete remission (CR) without any subsequent relapse. At 22 months (median, range 1-113), 20 patients (83.3%) are alive at the time of report. Three patients died during acute episode because of sever disease or delayed treatment and one died in CR. CONCLUSION: TPE, steroids and or rituximab was very effective in preventing high risk of mortality and achieving durable CR in 87.5% of patients. More awareness is needed for early diagnosis and early referral to centers with appropriate tertiary care facilities.. Professional Medical Publications 2016 /pmc/articles/PMC5216308/ /pubmed/28083052 http://dx.doi.org/10.12669/pjms.326.11274 Text en Copyright: © Pakistan Journal of Medical Sciences http://creativecommons.org/licenses/by/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Iqbal, Shahid Zaidi, Syed Z. A. Motabi, Ibraheem H Alshehry, Nawal Faiez AlGhamdi, Mubarak S. Tailor, Imran Khan Thrombotic thrombocytopenic purpura - analysis of clinical features, laboratory characteristics and therapeutic outcome of 24 patients treated at a Tertiary Care Center in Saudi Arabia |
title | Thrombotic thrombocytopenic purpura - analysis of clinical features, laboratory characteristics and therapeutic outcome of 24 patients treated at a Tertiary Care Center in Saudi Arabia |
title_full | Thrombotic thrombocytopenic purpura - analysis of clinical features, laboratory characteristics and therapeutic outcome of 24 patients treated at a Tertiary Care Center in Saudi Arabia |
title_fullStr | Thrombotic thrombocytopenic purpura - analysis of clinical features, laboratory characteristics and therapeutic outcome of 24 patients treated at a Tertiary Care Center in Saudi Arabia |
title_full_unstemmed | Thrombotic thrombocytopenic purpura - analysis of clinical features, laboratory characteristics and therapeutic outcome of 24 patients treated at a Tertiary Care Center in Saudi Arabia |
title_short | Thrombotic thrombocytopenic purpura - analysis of clinical features, laboratory characteristics and therapeutic outcome of 24 patients treated at a Tertiary Care Center in Saudi Arabia |
title_sort | thrombotic thrombocytopenic purpura - analysis of clinical features, laboratory characteristics and therapeutic outcome of 24 patients treated at a tertiary care center in saudi arabia |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216308/ https://www.ncbi.nlm.nih.gov/pubmed/28083052 http://dx.doi.org/10.12669/pjms.326.11274 |
work_keys_str_mv | AT iqbalshahid thromboticthrombocytopenicpurpuraanalysisofclinicalfeatureslaboratorycharacteristicsandtherapeuticoutcomeof24patientstreatedatatertiarycarecenterinsaudiarabia AT zaidisyedza thromboticthrombocytopenicpurpuraanalysisofclinicalfeatureslaboratorycharacteristicsandtherapeuticoutcomeof24patientstreatedatatertiarycarecenterinsaudiarabia AT motabiibraheemh thromboticthrombocytopenicpurpuraanalysisofclinicalfeatureslaboratorycharacteristicsandtherapeuticoutcomeof24patientstreatedatatertiarycarecenterinsaudiarabia AT alshehrynawalfaiez thromboticthrombocytopenicpurpuraanalysisofclinicalfeatureslaboratorycharacteristicsandtherapeuticoutcomeof24patientstreatedatatertiarycarecenterinsaudiarabia AT alghamdimubaraks thromboticthrombocytopenicpurpuraanalysisofclinicalfeatureslaboratorycharacteristicsandtherapeuticoutcomeof24patientstreatedatatertiarycarecenterinsaudiarabia AT tailorimrankhan thromboticthrombocytopenicpurpuraanalysisofclinicalfeatureslaboratorycharacteristicsandtherapeuticoutcomeof24patientstreatedatatertiarycarecenterinsaudiarabia |